Logo-apb
Adv Pharm Bull. 2019;9(4): 578-583.
doi: 10.15171/apb.2019.066
PMID: 31857961
PMCID: PMC6912181
Scopus ID: 85075836083
  Abstract View: 1198
  PDF Download: 915

Research Article

Niosomal Benzoyl Peroxide and Clindamycin Lotion Versus Niosomal Clindamycin Lotion in Treatment of Acne Vulgaris: A Randomized Clinical Trial

Saman Mohammadi 1 ORCID logo, Abbas Pardakhty 2 ORCID logo, Maryam Khalili 1 ORCID logo, Reza Fathi 1 ORCID logo, Maryam Rezaeizadeh 2 ORCID logo, Saeedeh Farajzadeh 3, Azadeh Mohebbi 1 ORCID logo, Mahin Aflatoonian 1* ORCID logo

1 Department of Dermatology, Afzalipour Hospital, Kerman University of Medical Sciences, Kerman, Iran.
2 Pharmaceutics Research Center, Neuropharmacology Institute, Kerman University of Medical Sciences, Kerman, Iran.
3 Leishmaniasis Research Center, Afzalipour Hospital, Kerman University of Medical Sciences, Iran.
*Corresponding Author: Email: aflatoonian@kmu.ac.ir

Abstract

Purpose: Combination of benzoyl peroxide (BPO) with topical antibiotics can lead to higher efficacy and less bacterial resistance, but it in turn increases adverse effects such as skin irritability and dryness. In this study, the efficacy of combination therapy of niosomal BPO 1% and clindamycin (CL) 1% is compared with niosomal CL in acne vulgaris.

Methods: This is a double-blind clinical trial study on 100 patients with acne vulgaris in Afzalipour hospital in Kerman. Patients were randomly divided into 2 groups (case and control). The case group received niosomal combination of BPO 1% and CL 1%.The control group received niosomal CL1%. The efficacy of treatment protocols was evaluated in 2nd, 4th, 8th and 12th weeks of treatment by counting lesions (severity and grading acne lesions) and quality of life (QoL). Furthermore, side effect were evaluated at each treatment visits.

Results: The reduction in mean percentage of acne lesions in case group (treated with BPO 1% and CL1%) (64.21%) was higher than control group (treated with niosomal CL 1%) (59.04%), but the statistical difference was not significant. Sum of excellent and good results were found in 80% and 76.1% of case and control groups, respectively (P=0.377). Also adding BPO to the treatment formulation in case group did not increase adverse effects, as statistical difference between 2 groups was not significant.

Conclusion: Combination of niosomal BPO 1% and CL 1% in treatment of acne vulgaris showed higher efficacy with no increase in adverse effects in comparison with niosomal CL 1%, but the statistical difference was not significant.


First Name
 
Last Name
 
Email Address
 
Comments
 
Security code


Abstract View: 1199

Your browser does not support the canvas element.


PDF Download: 915

Your browser does not support the canvas element.

Submitted: 22 Dec 2018
Revision: 11 Jun 2019
Accepted: 24 Jun 2019
ePublished: 24 Oct 2019
EndNote EndNote

(Enw Format - Win & Mac)

BibTeX BibTeX

(Bib Format - Win & Mac)

Bookends Bookends

(Ris Format - Mac only)

EasyBib EasyBib

(Ris Format - Win & Mac)

Medlars Medlars

(Txt Format - Win & Mac)

Mendeley Web Mendeley Web
Mendeley Mendeley

(Ris Format - Win & Mac)

Papers Papers

(Ris Format - Win & Mac)

ProCite ProCite

(Ris Format - Win & Mac)

Reference Manager Reference Manager

(Ris Format - Win only)

Refworks Refworks

(Refworks Format - Win & Mac)

Zotero Zotero

(Ris Format - Firefox Plugin)